Scintigraphic localization of a disseminated malignant pheochromocytoma with the use of 131I-meta-iodobenzylguanidine

Luigi Troncone, Cl Maini, Giovina De Rosa, Salvatore Maria Corsello, Vittoria Rufini, Osvaldo Mattei, N. Bonifazi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Preliminary clinical studies with 131I-meta-iodobenzylguanidine, a newly synthesized radiopharmaceutical and guanethidine analog capable of imaging the adrenal medulla, have led to the identification of a case of disseminated malignant pheochromocytoma with the localization of brain and bone metastases. The result is of particular interest as the symptomatology in this case appeared rather equivocal and various investigations had led to a completely different diagnosis. This new scintigraphic technique has proved to be safe, specific and noninvasive, and it may have a clinical application as a complementary or alternative technique to conventional diagnostic tests.
Original languageEnglish
Pages (from-to)429-432
Number of pages4
JournalEuropean Journal Of Nuclear Medicine
Volume9
Publication statusPublished - 1984

Keywords

  • 3-Iodobenzylguanidine
  • Adrenal Gland Neoplasms
  • Adult
  • Bone Neoplasms
  • Brain Neoplasms
  • Humans
  • Iodine Radioisotopes
  • Iodobenzenes
  • Male
  • Pheochromocytoma

Fingerprint

Dive into the research topics of 'Scintigraphic localization of a disseminated malignant pheochromocytoma with the use of 131I-meta-iodobenzylguanidine'. Together they form a unique fingerprint.

Cite this